Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Furthermore, blockade of the IL-6 receptor with tocilizumab reduces meal-stimulated levels of GLP-1 in people with type 2 diabetes or obesity [129]
Sources: Martnez-Gmez, Mario G., and Brandon M
About this article Cite this article Forouzanmehr, B., Hemmati, M.A., Atkin, S.L
Back to Journals Drug Design, Development and Therapy Volume 12 Glutathione S -transferase : a potential role in antitumor therapy Authors Dong S, Sha H, Xu X, Hu T, Lou R, Li H, Wu J, Dan C, Feng J Received 31 March 2018 Accepted for publication 27 June 2018 Published 23 October 2018 Volume 2018:12 Pages 35353547 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Professor Anastasios Lymperopoulos Shu-Chen Dong, 1, * Huan-Huan Sha, 1, * Xiao-Yue Xu, 1 Tian-Mu Hu, 2 Rui Lou, 1 Huizi Li, 1 Jian-Zhong Wu, 1 Chen Dan, 1 Jifeng Feng 1 1 Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Nanjing Medical University Affiliated Cancer Hospital, Nanjing 210009, China
US$ 28.68
US$ 25.26
US$ 29.07
US$ 28.19
US$ 23.15
